Anaergia Announces Delay in the Filing of Its Audited Financial Statements and Related Disclosures

BURLINGTON, Ontario -- Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today that there will be a delay in the filing of its annual information form for the year ended December 31, 2023, audited annual consolidated financial statements for the year ended December 31, 2023, the related management’s discussion and analysis of financial condition and results of operations and CEO and CFO certificates relating to the audited annual financial statements as required by National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings (collectively, the “Required Documents”) beyond the April 1, 2024 filing deadline. Read More